Search
for
Sort by
Research 931–960 of 1000+
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Monilethrix: A Novel Mutation (Glu402Lys) in the Helix Termination Motif and the First Causative Mutation (Asn114Asp) in the Helix Initiation Motif of the Type II Hair Keratin hHb6
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Skin-type-dependent development of murine mechanosensory neurons
- Hair follicle characteristics as early marker of Type 2 Diabetes
- Design of an artificial skin. IV. Use of island graft to isolate organ regeneration from scar synthesis and other processes leading to skin wound closure
- Implications of a Clinically Ignored Site of Acanthosis Nigricans: The Knuckles
- Pathomechanism of androgenetic alopecia and new treatment
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Cell type‐specific actions of thyroid hormones in nonalcoholic steatohepatitis and liver fibrosis
- Improving Rural Nurse Practitioner Knowledge About Polycystic Ovary Syndrome Through Continuing Education
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Management OF Patients with Polycystic Ovary Syndrom
- Recombinant Type XVII Collagen Promotes Hair Growth by Activating the Wnt/β-Catenin and SHH/GLI Signaling Pathways
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- ANDROGENINĖS ALOPECIJOS MEDIKAMENTINIO GYDYMO GALIMYBĖS
- Type D Personality, Stress Levels, and Coping Strategies in Women with Androgenetic Alopecia and Polycystic Ovary Syndrome
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- Clinical aspects of the metabolic syndrome
- Evaluation of hyperandrogenemia and metabolic risk profile in women with postadolescent acne
- Metabolic Aspects of Polycystic Ovary Syndrome
- Diagnostic approach to low‐renin hypertension
- Does degree of baldness influence vitamin D status?
- Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial